Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.
Orlandi P, Banchi M, Vaglini F, Carli M, Aringhieri S, Bandini A, Pardini C, Viaggi C, Lai M, Alì G, Ottani A, Vandini E, Guidi P, Bernardeschi M, La Rocca V, Francia G, Fontanini G, Pistello M, Frenzilli G, Giuliani D, Scarselli M, Bocci G.
Orlandi P, et al. Among authors: scarselli m.
Biochem Pharmacol. 2024 Jan;219:115952. doi: 10.1016/j.bcp.2023.115952. Epub 2023 Nov 29.
Biochem Pharmacol. 2024.
PMID: 38036189
Free article.